Asset Details
Do you wish to reserve the book?
Omadacycline for Acute Bacterial Skin and Skin-Structure Infections
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Omadacycline for Acute Bacterial Skin and Skin-Structure Infections
Do you wish to request the book?
Omadacycline for Acute Bacterial Skin and Skin-Structure Infections
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Omadacycline for Acute Bacterial Skin and Skin-Structure Infections
2019
Overview
Treatment for acute bacterial skin and skin-structure infections is becoming more challenging as organisms with antimicrobial resistance become more prevalent. In this randomized trial involving 655 adults with bacterial skin and skin-structure infections, omadacycline was noninferior to linezolid regardless of the causative pathogen, including MRSA.
Publisher
Massachusetts Medical Society
Subject
/ Adult
/ Aged
/ Anti-Bacterial Agents - adverse effects
/ Anti-Bacterial Agents - therapeutic use
/ Bacteria
/ Drug Administration Schedule
/ Female
/ Humans
/ Male
/ Methicillin-Resistant Staphylococcus aureus - drug effects
/ Patients
/ Skin
/ Skin Diseases, Bacterial - drug therapy
/ Skin Diseases, Bacterial - microbiology
/ Survival
/ Tetracyclines - adverse effects
/ Tetracyclines - therapeutic use
/ Ulcers
